Fresenius Medical Care (FMS) Tops Q3 EPS Views

Fresenius Medical Care (NYSE: FMS) reported Q3 EPS of $1.09, $0.57 better than the analyst estimate of $0.52. Revenue for the quarter came in at $4.6 billion versus the consensus estimate of $4.55 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Freedom Broker Starts Copart (CPRT) at Buy
• Orion Digital receives Nasdaq minimum bid price deficiency notice